Robinson Value Management, Ltd. Amgen Inc Transaction History

Robinson Value Management, Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $1.13 Million - $1.32 Million	-5,306 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$233.58 - $259.14 $4,204 - $4,664	-18 Reduced 0.34%	5,306 $1.29 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $61,469 - $71,632	-277 Reduced 4.95%	5,324 $1.33 Million
Q4 2020 Feb 19, 2021	SELL	$216.38 - $257.67 $1.25 Million - $1.49 Million	-5,772 Reduced 50.75%	5,601 $1.29 Million
Q4 2019 Feb 06, 2020	SELL	$189.21 - $243.2 $140,772 - $180,940	-744 Reduced 6.14%	11,373 $2.74 Million
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $182,203 - $213,583	-1,093 Reduced 8.27%	12,117 $2.23 Million
Q3 2018 Nov 02, 2018	SELL	$185.29 - $208.89 $80,230 - $90,449	-433 Reduced 3.17%	13,210 $0
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $67,748 - $76,096	-408 Reduced 2.9%	13,643 $0
Q1 2018 Apr 18, 2018	BUY	$169.43 - $198.0 $1.7 Million - $1.99 Million	10,051 Added 251.28%	14,051 $2.4 Million
Q3 2017 Nov 16, 2017	BUY	$167.29 - $191.0 $669,160 - $764,000	4,000	4,000 $746,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Robinson Value Management, Ltd., based on Form 13F filings with the SEC.

Stay updated on Robinson Value Management, Ltd. with notifications on news.